ロード中...
Methods and Designs of Modern Breast Cancer Confirmatory Trials
SIMPLE SUMMARY: The benefit–risk assessments of new drugs for breast cancer (BC) face several challenges, as all stakeholders do not agree on the evidence bar required for market authorization, and by the fragmentation of breast cancer diagnosis. In this study, we describe the methods and designs of...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8199547/ https://ncbi.nlm.nih.gov/pubmed/34199352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112757 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|